(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DTECT-ALL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DTECT-ALL

ST13

US500000088144649

Class

1, 5, 9, 42

Filing

88144649

Registration

6010862

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

03/17/2025

Trademark type

Word

Nice classes

1, 5, 9, 42

Filing date

10/05/2018

Registration date

03/17/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/17/2020

Last transaction

03/17/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

ILLKIRCH-GRAFFENSTADEN, FR

Examiner

HUNT, LEE

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

D. T. (pessoa física)

Representatives

Jeffrey M. Goehring Nixon & Vanderhye P.C.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical additives used in the biotechnology and pharmaceutical industries; Chemicals used for biotechnology industry; Chemicals used for biological purposes in the field of industry; biological preparations for use in biotechnological industry and science; Chemical reagentsother than for medical or veterinary purpose

Class 5

Chemical preparations used in the pharmaceutical industries for treating cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases; Chemicals used for biological purposes in the medical field; Chemicals used in the medical and veterinary industries; biological preparations for use in the medical and veterinary industries for the treatment of cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases; biological preparations for use in the pharmaceutical industry for medical treatment of cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases; biological preparations for use in pharmaceuticals industry in the field of industry and science; Pharmaceutical and veterinary pharmaceutical preparations for treating cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; medical or biological diagnostic tests for diagnosing cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases; medical or biological diagnostic tests for the identification of molecules for treating cancerimmune disorderscentral nervous system diseasesrare diseasesinflammatory diseasesmetabolic diseases or cardiovascular diseases

Class 9

Scientific apparatus and instrumentsfor the measurement of biologicalpharmacologicalpsychological or chemical phenomenafor measuring interactions between chemicalsmoleculesproteinsantibodies and peptides with their targets

Class 42

Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discoveringidentifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use

Publications

History of USPTO decisions and trademark events.

31 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

03/17/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/23/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/23/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

03/17/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2019

PUBO

PUBLISHED FOR OPPOSITION

12/31/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

11/27/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/19/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/19/2019

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

11/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/21/2019

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

08/21/2019

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

04/23/2019

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/19/2019

ALIE

ASSIGNED TO LIE

04/12/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/22/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/19/2019

GNSL

LETTER OF SUSPENSION E-MAILED

03/19/2019

CNSL

SUSPENSION LETTER WRITTEN

03/19/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/25/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/25/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/25/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

01/17/2019

GNRT

NON-FINAL ACTION E-MAILED

01/17/2019

CNRT

NON-FINAL ACTION WRITTEN

01/17/2019

DOCK

ASSIGNED TO EXAMINER

01/16/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/16/2018

NWAP

NEW APPLICATION ENTERED

10/09/2018

Continuous trademark protection

Get notified about every new filing that threatens DTECT-ALL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.